Skip to main content
Caplight Logo









Ryght AI

Ryght AI

Private
Laguna Beach, CaliforniaHealthcare & Life Scienceshttps://www.ryght.ai/

Last Round

Strategic

Dec 11, 2025

Total Funding Raised

$3M

Company Overview

Ryght AI is a healthcare technology company that provides a generative and agentic AI platform to automate and accelerate clinical trial site selection, activation, and enrollment.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, NLP & Conversational AI, Workflow Automation, Drug Discovery

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

generative AIclinical trial automationclinical trial managementlife sciences AIpharma AIclinical research organizationCROsite activationworkflow automationagentic AIAI agentdrug development softwareSaaS platformclinical data managementvertical AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ryght AI Comparables

Compare Ryght AI with similar companies based on industry and business-model similarity.

Ryght AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kitsa
87%
Cori Clinical
84%
AlphaLife Sciences
83%

Ryght AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 11, 2025
SeedJun 12, 2025
SeedJun 27, 2023

Ryght AI Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Launched RyghtSites.com, a free AI-powered clinical trial search engine.

  • Aug 15, 2025

    Partnered with Biorasi for clinical trial site activation.

Recent news

Latest coverage and updates

  • attends_eventOct 2, 2026

    Ryght, Inc.'s Director of Business Development, Dylan Wallace, presents how AI Site Twins help sponsors and CROs make more informed clinical trial site decisions at BioTechX USA 2026 in Massachusetts on Sep 29th-30th '26.

  • has_revenueAug 10, 2026

    Ryght, Inc. had revenue of $2.8M on Nov 1st '25.

Ryght AI Filings

Explore SEC and related filing metadata, where available.

Ryght AI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ryght AI's valuation, stock price, and market status.

Is Ryght AI a public or private company?

Ryght AI is a private company.

What is the current stock price of Ryght AI?

Ryght AI is a private company, so its shares have no public market price. Caplight tracks Ryght AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ryght AI worth (valuation)?

Valuation information for Ryght AI is not publicly available.

Can I buy Ryght AI stock?

Ryght AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ryght AI's last funding round?

Ryght AI's most recent funding round was Strategic on December 11, 2025.

Who are the main investors in Ryght AI?

Key investors in Ryght AI include Foothill Ventures, Accenture Ventures, Virtue.

Will Ryght AI IPO soon?

No public IPO plans have been announced for Ryght AI.

How can I track Ryght AI secondary market activity?

Caplight tracks bids, offers, and trades in Ryght AI's shares on secondary markets.

Firmographic Details

HeadquartersLaguna Beach, California
Employee Range27
Year Founded2024
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?